| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.05. | The Analyst Verdict: Corcept Therapeutics In The Eyes Of 4 Experts | 2 | Benzinga.com | ||
| 02.05. | Corcept (CORT) Q1 Earnings & Revenues Surpass Estimates | 1 | Zacks | ||
| 02.05. | Earnings call: Corcept Therapeutics raises 2024 revenue guidance | 2 | Investing.com | ||
| 02.05. | Corcept Therapeutics Inc reports results for the quarter ended in March - Earnings Summary | 6 | Reuters | ||
| 01.05. | CORCEPT THERAPEUTICS INC - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 01.05. | Corcept Therapeutics Incorporated: Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Update | 12 | GlobeNewswire (Europe) | MENLO PARK, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe... ► Artikel lesen | |
| 24.04. | Corcept Therapeutics Incorporated: Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call | 1 | GlobeNewswire (USA) | ||
| 23.04. | Corcept (CORT) Posts Positive Data From Cushing's Syndrome Study | 2 | Zacks | ||
| 22.04. | Mid-Cap Corcept Therapeutics Reveals Data From Hormonal Disorder Study, FDA Application Submission Expected This Quarter | 1 | Benzinga.com | ||
| 22.04. | Corcept falls on limited data from late-stage trial of Cushing's syndrome drug | 1 | Reuters | ||
| 22.04. | Corcept falls after phase 3 results on Cushing's candidate doesn't include some data | 4 | Seeking Alpha | ||
| 17.04. | CORCEPT THERAPEUTICS INC - 8-K, Current Report | 3 | SEC Filings | ||
| 16.04. | Corcept (CORT) Completes Enrollment in Phase II ALS Study | 1 | Zacks | ||
| 09.04. | Corcept (CORT) Completes Enrollment in Ovarian Cancer Study | 3 | Zacks | ||
| 25.03. | Will Corcept (CORT) Bank on Korlym in 2024 Amid Stiff Rivalry? | 1 | Zacks | ||
| 16.02. | Corcept (CORT) Q4 Earnings Beat Estimates, Korlym Sales Grow | 4 | Zacks | ||
| 16.02. | What's Going On With Stress Hormone Modulator-Focused Corcept Therapeutics' Stock Friday? | 3 | Benzinga.com | ||
| 16.02. | Earnings call: Corcept Therapeutics reports strong Q4, optimistic about 2024 | 3 | Investing.com | ||
| 16.02. | Corcept Therapeutics Inc reports results for the quarter ended in December - Earnings Summary | 3 | Reuters | ||
| 15.02. | Corcept Therapeutics GAAP EPS of $0.28 beats by $0.02, revenue of $135.4M beats by $6.1M | 3 | Seeking Alpha |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 1.679 |
| BAYER | 1.436 |
| NEL | 1.348 |
| TUI | 1.212 |
| PLUG POWER | 1.172 |
| NOVAVAX | 1.158 |
| SIEMENS ENERGY | 1.138 |
| MERCEDES-BENZ | 1.104 |
| PALANTIR TECHNOLOGIES | 784 |
| ALLIANZ | 737 |
| NVIDIA | 735 |
| RWE | 702 |
| DEUTSCHE BANK | 681 |
| BYD | 638 |
| BASF | 594 |
| DEUTSCHE LUFTHANSA | 585 |
| RHEINMETALL | 559 |
| TESLA | 547 |
| VOLKSWAGEN | 521 |
| INFINEON | 506 |
| COMMERZBANK | 505 |
| NORDEX | 483 |
| AIXTRON SE | 482 |
| STANDARD LITHIUM | 463 |
| RENK GROUP | 462 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
